| ||
| BLAs Accepted for Brentuximab Vedotin - MPR Medications used to treat ovarian cancer. FDA-Approved Non-small cell lung cancer (NSCLC) Drug Treatments. September 24, 2009. Medications used to treat non-small cell lung cancer (NSCLC). FDA-Approved Colorectal Cancer Drug Treatments ... Latest articles from MPR - http://www.empr.com/ |
| ||
| Frequent homozygous deletion of the LKB1/STK11 gene in non-small ... Life Science Analytics', Lung Cancer and Non-Small Cell Lung Cancer Therapy Area Pipeline Report contains detailed information on the lung cancer and ... www.bioportfolio.com/.../Frequent-Homozygous-Deletion-Of-... | ||
| ASCO issues Provisional Clinical Opinion on EGFR testing in Non ... Hot off the electronic press is the PCO issued by ASCO recommending that patients with advanced stage NSCLC should have their tumors tested for EGFR ... pathlabmed.typepad.com/.../asco-issues-provisional-clinical-op... | ||
| Klotho predicts good clinical outcome in patients with limited ... The important role of surgery in early-stage small cell lung cancer (SCLC) has been recognized, and curative surgical resection is recommended. ... www.lungcancerjournal.info/article/S0169...4/abstract | ||
| Proteomic analysis of resectable non-small cell lung cancer: post ... A prospective study was undertaken on patients undergoing curative resection for non-small cell lung cancer (NSCLC): we used SELDI-TOF-MS to compare the ... icvts.ctsnetjournals.org/cgi/content/.../icvts.2010.260166v1 |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment